As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In today's ACT Brief, we explore the operational capabilities clinical teams need to implement Bayesian trial designs, why gender diversity strengthens data science across drug development, and the ...